STAT3, a key regulator in liver fibrosis.

This article reviewed the recent studies on STAT3 in the development of various liver fibrosis to find a more effective method to relieve and cure liver diseases, such as hepatitis B virus (HBV), non-alcoholic fatty liver disease (NAFLD), schistosomiasis, and chemical liver injury. PMID: 32702499 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32702499?dopt=Abstract

Source: Annals of Hepatology - July 25, 2020 Category: Gastroenterology Tags: Ann Hepatol Source Type: research